Drugs.com Press Releases
Q3 2012 Drug Sales Data Released: Nexium and Abilify Remain the Leading Brands
November 21, 2012 -- The latest U.S. drug sales data has been released by Drugs.com. As in the previous quarter, proton-pump inhibitors, antipsychotics and statins remain in the top-selling therapeutic categories. Merck’s asthma and allergy preventive Singulair predictably drops out of the top five drugs due to Q3 patent loss. AstraZeneca’s Nexium, not forecast to lose patent protection until May 2014, once again holds the top spot with over $1.42 billion in sales.
Latest Drug Sales Data Released: Loss of Patent Protection Has Significant Effect
August 15, 2012 -- Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Plavix and Seroquel dip in second quarter due to loss of patent protection.
Top 100 Drug Sales Data Released - Plavix Leads the Way
July 18, 2012 -- Drugs.com, the leading online clinical drug resource, today released first quarter 2012 U.S. prescription sales data for the top 100 drugs. Blood-thinners, proton-pump inhibitors, antipsychotics and asthma therapeutic categories continue to remain top sellers.
New iPhone App by Drugs.com Reminds Patients to Take Medications on Time
September 20, 2011 -- Drugs.com announces a new iPhone App, "My Meds” - A personal medication record (PMR) and pill reminder app designed to help manage prescription medications and improve patient compliance.
FDA Announces Collaboration with Drugs.com
May 26, 2010 -- The United States Food and Drug Administration has announced that it will collaborate with the Web site Drugs.com to expand access to the FDA's consumer health information.